Shan La Mei Ye

Shan La Mei Ye (Calycanthi Folium) is the dried leaf of Calycanthus chinensis W. C. Cheng et S. Y. Chang, a deciduous shrub in the family Calycanthaceae. In the traditional TCM classification system, Shan La Mei Ye is considered bitter in flavor with a cool nature. It enters the Lung meridian, giving it a role in formulas that address Lung Heat, toxicity, and inflammatory conditions. Shan La Mei Ye is primarily used in regional herbal traditions of eastern China, particularly in Jiangxi and Zhejiang provinces.

Botanical description: Calycanthus chinensis is a deciduous shrub growing 2–4 meters tall. The plant has a spreading habit with multiple stems arising from the base. The leaves are opposite, ovate to elliptic-ovate, 7–15 cm long and 3–8 cm wide, with an acuminate apex, a cuneate base, and finely serrated margins. The leaf surface is dark green and glabrous above, lighter gray-green and pubescent below, with prominent lateral veins (typically 6–10 pairs) that are sunken on the upper surface and raised on the lower surface. The petioles are 5–10 mm long. The flowers are solitary, terminal, and cup-shaped, 4–7 cm in diameter, with brownish-yellow to reddish-brown petals that have a spicy, camphoraceous fragrance. The fruit is an achene enclosed in a leathery, urn-shaped receptacle. The leaves are harvested in summer and autumn and dried in the shade to preserve their active constituents.

Habitat and cultivation: C. chinensis is native to eastern China and is found in Jiangxi, Zhejiang, Anhui, Fujian, and Hubei provinces. It grows in mountain forests, thickets, and along stream banks at elevations of 500–2,000 meters. The plant is also cultivated as an ornamental for its fragrant flowers and attractive foliage, and can be found in botanical gardens worldwide. The leaves are primarily wild-harvested from natural populations, though some cultivation occurs in its native range for medicinal use. The plant prefers partial shade, moist but well-drained soil, and a temperate climate.

Quality markers: High-quality Shan La Mei Ye should have intact, dark green leaves with prominent veins, a clean appearance, and a mild aromatic odor. The material should be free from mold, excessive stem material, and contamination. Due to the limited commercial scale and primarily wild-harvested origin, quality can vary. The alkaloid content, particularly calycanthine, is an important consideration for both quality and safety purposes. Proper processing (drying in the shade, appropriate storage) is essential to maintain quality and minimize degradation of active compounds.

Taxonomic and regional context: The genus Calycanthus includes several species distributed in East Asia and North America. C. chinensis is the species used in TCM and is endemic to China. Related species include C. floridus (Carolina allspice) from eastern North America and C. occidentalis (California spicebush) from western North America. All Calycanthus species contain calycanthine and related alkaloids, though the content varies by species and plant part. The seeds tend to have higher alkaloid content than the leaves. Shan La Mei Ye is one of several regional Chinese herbs that have been incorporated into the broader materia medica through provincial pharmacopoeias rather than the national-level Chinese Pharmacopoeia.

In the traditional Chinese medicine theoretical framework, Shan La Mei Ye enters the Lung meridian and has a bitter, cool quality. It is traditionally indicated for Lung Heat and heat-toxin patterns. Its use is primarily documented in the regional herbal traditions of Jiangxi and Zhejiang provinces in eastern China.

Clearing Lung Heat and relieving cough: Shan La Mei Ye is traditionally used to clear Heat from the Lung and relieve coughing. In TCM theory, Lung Heat may present as cough with yellow or sticky Phlegm, shortness of breath, chest discomfort, and a red tongue with yellow coating. The bitter and cool properties of Shan La Mei Ye are considered appropriate for addressing the Heat component. It is used in regional formula traditions for acute and chronic cough with Heat signs, including acute bronchitis and tracheitis in the context of Lung Heat patterns. The bitter flavor is traditionally understood to "dry" Heat-related moisture (Damp-Heat) in the Lung, while the cool nature directly counteracts Heat.

Resolving toxicity and reducing swelling: Shan La Mei Ye has a traditional reputation for resolving toxicity (jie du) and reducing swelling. It has been used for heat-toxin patterns presenting as sore throat, swollen lymph nodes, and localized inflammation. In some folk traditions, the leaves are used externally as a wash or poultice for inflammatory skin conditions and swelling. The toxicity-resolving action is attributed to the herb's bitter and cool properties, which are traditionally understood to counteract heat-toxin and reduce inflammatory swelling. This use is consistent with the general TCM principle that bitter-cool herbs clear Heat and resolve toxicity.

Regional tradition and documentation: Shan La Mei Ye is primarily documented in the herbal traditions of Jiangxi and Zhejiang provinces. It appears in the Jiangxi Province Standard for Chinese Materia Medicaand regional materia medica texts. The State Administration of Traditional Chinese Medicine included Shan La Mei Ye in the Zhong Hua Ben Cao (Chinese Materia Medica), Volume on Folk Medicines, documenting its traditional uses for clearing Heat, resolving toxicity, and relieving cough. Its use is more prominent in folk and regional practice than in the major canonical formula literature, reflecting its status as a regional specialty herb rather than a nationally standardized TCM herb.

Shan La Mei Ye contains a range of chemical constituents with varying pharmacological profiles. The most notable is calycanthine, which is both the most studied and the most concerning compound from a safety perspective. The following summarizes the major constituents and what is currently known about them.

Calycanthine (CRITICAL SAFETY CONCERN): Calycanthine is a quinolizidine alkaloid that is the most notable and concerning constituent of Calycanthus species. It has been studied for its neuropharmacological effects and has been demonstrated to possess convulsant (seizure-inducing) properties in animal studies. Kudo et al. (1981) showed that calycanthine acts as a competitive antagonist at strychnine-sensitive glycine receptors in the central nervous system, which is the primary mechanism underlying its convulsant activity (PMID: 6289683). Glycine receptors are inhibitory receptors in the brainstem and spinal cord, and their blockade leads to disinhibition of motor neurons, resulting in seizures. The calycanthine content varies depending on the plant part, season, and processing method. Proper processing can reduce calycanthine levels, but the risk cannot be entirely eliminated. This is the principal safety concern for Shan La Mei Ye and the reason for its "avoid" safety classification.

Other alkaloids: Additional alkaloids have been identified in Calycanthus species, including chimonanthine and folicanthine. These are structural isomers and analogues of calycanthine that share some of its neuropharmacological properties. Chimonanthine has been reported to have convulsant activity similar to calycanthine, though it may be less potent. The total alkaloid content contributes to the overall toxicity profile and must be considered in safety assessments. These alkaloids are present in all parts of the plant, though typically at higher concentrations in the seeds than in the leaves.

Flavonoids: The flavonoid fraction of Shan La Mei Ye includes various flavonoid glycosides and aglycones that have demonstrated antioxidant and anti-inflammatory activities in pre-clinical models. Li et al. (2018) isolated antioxidant flavonoids from Calycanthus chinensis leaves and demonstrated free radical scavenging activity in standard assays (PMID: 29464468). These compounds are considered to contribute to the herb's traditional Heat-clearing properties and may have a more favorable safety profile compared to the alkaloid fraction. The flavonoid content represents a potentially beneficial component of the herb, but it must be weighed against the calycanthine toxicity concern.

Volatile oils: The leaves contain volatile oils that contribute the herb's aromatic properties. These include terpenoid and aromatic compounds that may have antimicrobial and anti-inflammatory activities. Wang et al. (2015) reported on the chemical constituents of Calycanthus chinensis leaves, identifying various volatile compounds (PMID: 26281535). The volatile oil fraction may contribute to the herb's traditional use for respiratory conditions, as aromatic compounds are commonly used in TCM for their ability to "open the orifices" and disperse stagnation.

The compounds listed above are identified through phytochemical analysis. The calycanthine content represents a serious safety concern that must not be overlooked. Their pharmacological activities are based on pre-clinical studies and do not represent confirmed clinical effects in humans.

Shan La Mei Ye is used in regional formula traditions of eastern China rather than in the major classical formula canon. Below are three representative formulas that incorporate Shan La Mei Ye.

The following section summarizes published research on Calycanthus chinensis and its constituents. Unless stated otherwise, studies are pre-clinical (animal models, in-vitro experiments).

Calycanthine pharmacology and toxicity: Calycanthine is the most studied constituent from a safety perspective. Research has established that calycanthine acts as a competitive antagonist at strychnine-sensitive glycine receptors in the central nervous system, which is the mechanism underlying its convulsant effects. Kudo et al. (1981) demonstrated dose-dependent seizures with calycanthine administration in animal models and characterized its pharmacological properties at the glycine receptor (PMID: 6289683). Glycine receptors are critical inhibitory receptors in the brainstem and spinal cord, and their blockade by calycanthine leads to hyperexcitability and seizures. This toxicity profile is the primary reason for the "avoid" safety classification of Shan La Mei Ye. The potency of calycanthine as a glycine receptor antagonist is comparable to strychnine, a well-known convulsant poison, though the calycanthine content in properly processed leaf material is lower than in seeds.

Antioxidant and anti-inflammatory activity: The flavonoid fraction of Calycanthus chinensis leaves has demonstrated antioxidant activity in free radical scavenging assays (DPPH, ABTS) and anti-inflammatory effects in cell-based models. Li et al. (2018) isolated and characterized antioxidant flavonoids from Calycanthus chinensis leaves, reporting significant free radical scavenging activity (PMID: 29464468). These pre-clinical findings provide some mechanistic support for the traditional Heat-clearing uses of the herb. The antioxidant and anti-inflammatory activities of the flavonoid fraction are consistent with the general pharmacology of flavonoids found in many medicinal plants. However, these beneficial properties must be weighed against the calycanthine toxicity concern.

Chemical constituent analysis: Wang et al. (2015) conducted a comprehensive analysis of the chemical constituents of Calycanthus chinensis leaves, identifying alkaloids, flavonoids, and volatile oil components (PMID: 26281535). This research provides a foundation for understanding the chemical complexity of Shan La Mei Ye and the need for careful quality control and standardization. The study highlighted the variable composition depending on harvest time and processing conditions.

Antimicrobial activity: The volatile oil and flavonoid fractions of Calycanthus leaves have shown antimicrobial activity against various bacterial species in in-vitro assays. These findings are from laboratory experiments and their clinical significance has not been established.

What the research does NOT show: The research does NOT demonstrate that Shan La Mei Ye is safe or effective for any specific condition in humans. There are no controlled clinical trials establishing efficacy. The calycanthine toxicity concern outweighs any potential benefits for unsupervised use. This page does not endorse Shan La Mei Ye as a treatment for any condition.

Important: The calycanthine content of this herb represents a serious safety concern. All pharmacological findings are pre-clinical. This section is provided for educational context and should not be used as a basis for treatment decisions.

CRITICAL SAFETY WARNING: Shan La Mei Ye has an "avoid" safety classification due to its calycanthine content, which has documented convulsant properties. The following information must be carefully considered by anyone considering the use of this herb.

Calycanthine neurotoxicity: Calycanthine is a glycine receptor antagonist that can induce seizures at sufficient doses in animal models (PMID: 6289683). While the calycanthine content in properly processed leaf material may be lower than in seeds or other plant parts, the risk cannot be entirely eliminated. Symptoms of calycanthine toxicity may include dizziness, nausea, muscle twitching, agitation, and in severe cases, tonic-clonic seizures. The onset of symptoms may be delayed after ingestion. Anyone experiencing neurological symptoms after exposure to Shan La Mei Ye should seek immediate medical attention.

Pregnancy and lactation: Absolutely contraindicated. The neurotoxic potential of calycanthine makes Shan La Mei Ye dangerous during pregnancy and lactation. Calycanthine can cross the placenta and may affect fetal brain development. Self-administration during pregnancy is absolutely not recommended under any circumstances.

Not for self-medication: Shan La Mei Ye should NEVER be used for self-medication. It should only be used under the direct supervision of a qualified TCM practitioner who understands its toxicity profile and can ensure proper processing, dosing, and monitoring. The margin between a therapeutic dose and a toxic dose may be narrow, and individual sensitivity to calycanthine varies.

Spleen-Stomach deficiency-cold: In TCM theory, its bitter and cool nature should be avoided in individuals with Spleen-Stomach deficiency-cold patterns (poor appetite, loose stools, abdominal coldness, pale tongue with white coating), as these properties may worsen digestive weakness.

Quality and processing concerns: The calycanthine content in Shan La Mei Ye varies depending on the plant part, harvest season, geographical origin, and processing method. There is no standardized quality control system that reliably ensures a safe calycanthine level. This variability adds an additional layer of uncertainty to the safety profile of this herb. Proper drying and storage are essential, but even well-processed material contains calycanthine.

Safer alternatives: For Lung Heat patterns and cough with Heat signs, many safer alternatives are available in the TCM materia medica, including Sang Bai Pi (Mulberry Root Bark), Di Gu Pi (Lycium Root Bark), Jin Yin Hua (Honeysuckle), and Lian Qiao (Forsythia). These herbs have better-characterized safety profiles and more extensive clinical documentation. The use of Shan La Mei Ye should be reserved for situations where a qualified practitioner determines it is specifically appropriate and can ensure proper monitoring.

This platform provides educational information. It does not recommend, endorse, or prescribe Shan La Mei Ye for any medical condition. The calycanthine content makes it dangerous for unsupervised use.